Experiment 518011
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | MILELR,VA: RIGAS,JR: FRANCIS,PA: GRANT,SC: PISTERS,KMW: VENKATRAMAN,ES: WOOLLEY,K: HEELAN,RT: KRIS,MG:. (1995). PHASE II TRIAL OF A 75-MG/M2 DOSE OF DOCETAXEL WITH PREDNISONE PREMEDICATION FOR PATIENTS WITH ADAVANCED NON-SMALL CELL LUNG CANCER.. 75(4) |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE II TRIAL WITH 20 PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER. PREMEDICATION WITH PREDNISONE DECREASED SOME SIDE EFFECTS BUT NOT THE NEUTROPENIA. |
| Dose amount | 75.0 MG |
| Number | 1 |
| Percent yield | 71% |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |
| Expression result | ILS |